- Aziyo Biologics ( NASDAQ: AZYO ) entered into a $25M credit facility from SWK.
- The new credit facility provides for an initial term loan of $21M that the company plans to use to fund its ongoing commercial and product development initiatives, refinance its existing debt facilities, and to pay off all such other outstanding debt.
- It also has the option to draw under the new credit facility an additional term loan of $4M based on achievement of specified operational and financial metrics by Sep.30, 2023.
- The loan facility enables for the establishment of a new asset-based revolving loan facility of up to $8M.
For further details see:
Aziyo Biologics signs $25M loan facility with SWK